Articles
For information related to a specific standard, enter the standard number in the search bar below. If no result is returned, contact your account advisor for guidance.
FDA and CDC Provide Updates for Monkeypox, COVID-19, and Ebola Testing
Federal agencies offer guidance on collecting, transporting, and shipping specimens for Ebola testing and ensuring authorized, valid, and ever-advancing tests for monkeypox and COVID-19 are available for use.
Home Infusion Therapy: Do Your Part for a Successful Survey
Your survey for ACHC Home Infusion Therapy Accreditation is a collaborative effort between the Surveyor and your agency. Each is responsible for performing certain duties to collectively ensure a successful survey experience.
Pharmacy: Do Your Part for a Successful Survey
Your survey for ACHC Pharmacy Accreditation is a collaborative effort between the Surveyor and your organization. Each is responsible for performing certain duties to collectively ensure a successful survey experience.
Coming Soon: Revisions to USP <795>, <797>
Many in the pharmacy industry welcome news that the United States Pharmacopeia (USP) plans to publish revised standards for USP General Chapters <795> and <797> on November 1, 2022. The announcement comes more than three years after USP first published proposed revisions in 2019.
Specimen Collection, Shelf-Life Extensions, and More
From best practices for collecting suspected monkeypox specimens to dealing with possible false negatives on COVID-19 testing, the CDC and the FDA provide updates and advice. Review the topics below and share the information with your networks.
Preparing for the End of the COVID-19 PHE
On July 15, Xavier Becerra, Secretary of Health and Human Services, extended the COVID-19 public health emergency declaration for another 90 days. One month later, on August 18, the Centers for Medicare & Medicaid Services (CMS) published a blog titled, “Creating a Roadmap for the End of the COVID-19 Public Health Emergency.”